Adial (ADIL) 10% Owner Coastlands Capital Buys Shares

What Happened Coastlands Capital LP, a disclosed 10% owner of Adial Pharmaceuticals (ADIL), acquired a total of 11,753 shares via open-market/private purchases across two days. On 2026-07-09 it bought 10,053 shares at $2.79 each (≈ $28,048) and on 2026-07-10 it bought 1,700 shares at $2.70 each (≈ $4,590), for combined cash outlay of about $32,638. These were purchases (Form 4 code P), which are direct acquisitions rather than sales.

Key Details

• Transaction dates and prices:
  • 2026-07-09: 10,053 shares @ $2.79 (≈ $28,048)
  • 2026-07-10: 1,700 shares @ $2.70 (≈ $4,590)
• Total shares purchased: 11,753; total cost: ≈ $32,638.
• Shares owned after the transactions: not specified in the information provided on this summary.
• Footnote: Coastlands Capital LP and related entities (Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew Perry) describe the adviser/GP structure and each disclaims group membership and beneficial ownership except to the extent of pecuniary interest.
• Filing: Form filed 2026-07-13 reporting transactions on 2026-07-09 and 2026-07-10 (timeliness not indicated here).

Context This filing reports institutional purchases by a 10% owner rather than an executive or director sale. Purchases can be interpreted as a straightforward acquisition of shares; the filing does not state any plan (e.g., 10b5-1) or other motive. For retail investors, institutional buys may be more informative than routine insider sales, but they do not guarantee future stock performance.